PathogenDx, a leader in next-generation microarray technology for better health and safety, saw a two-year 276% uptick in revenue and was the recipient of numerous awards and honors, including the Deloitte Technology Fast 500, Fast Company World Changing Ideas Award and Inc. Magazine 5000.
PathogenDX Recognized for Innovations and Growth